US Patent Issued to HENAN MEDINNO PHARMACEUTICAL TECHNOLOGY on Aug. 4 for "Solid forms of pharmaceutically acceptable salts of (S)-(2-ethyl-5-fluoro-4-hydroxyphenyl)-1H-indazol-3-yl)-4,6-dihydropyrrolo[3,4-dimidazol-5(1H)-yl)(3-hydroxypyrrolidin-1-yl)methanone as JAK inhibitors" (Chinese Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,289, issued on Aug. 4, was assigned to HENAN MEDINNO PHARMACEUTICAL TECHNOLOGY Co. LTD. (China).

"Solid forms of pharmaceutically acceptable salts of (S)-(2-ethyl-5-fluoro-4-hydroxyphenyl)-1H-indazol-3-yl)-4,6-dihydropyrrolo[3,4-dimidazol-5(1H)-yl)(3-hydroxypyrrolidin-1-yl)methanone as JAK inhibitors" was invented by Liang Lu (Zhengzhou, China) and Saisai Zhao (Zhengzhou, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to a JAK inhibitor compound and uses thereof. Specifically, the present disclosure discloses a compound of formula (G) in a solid form, isotopically labeled compound thereof, or optical isomer thereo...